Lyka Labs Ltd.
| BSE: 500259 | Sector: Health care |
| NSE: LYKALABS | ISIN Code: INE933A01014 |
| BSE 00:00 | 24 Jun | 118.10 |
0.05 (0.04%) |
OPEN
117.95 |
HIGH
119.05 |
LOW
115.15 |
| NSE 00:00 | 24 Jun | 118.45 |
1.15 (0.98%) |
OPEN
118.50 |
HIGH
119.50 |
LOW
116.05 |
| OPEN | 117.95 |
| PREVIOUS CLOSE | 118.05 |
| VOLUME | 10696 |
| 52-Week high | 267.20 |
| 52-Week low | 55.75 |
| P/E | 7.88 |
| Mkt Cap.(Rs cr) | 339 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Lyka Labs Ltd.
Lyka Labs Ltd
Initially manufacturing formulations Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83. It also added a range of ayurvedic and animal health care products over the years. In 1990 it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson US; Airsep Corporation US; Coloplast Denmark; and Te...> More
Lyka Labs Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
339 | |
| EPS - TTM | () |
[*S] | 14.99 |
| P/E Ratio | (X) | [*S] | 7.88 |
| Face Value | () |
10 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 15.49 |
| P/B Ratio | () |
[*S] | 7.62 |
Announcement
-
Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulati
-
Full And Final Payment Of Outstanding RSF 1 Facility And TL 2 Facility
-
Re-Schedulement Of 43Rd Annual General Meeting And Book Closure Period
-
Announcement under Regulation 30 (LODR)-Change in Directorate
Lyka Labs Ltd - Financial Results
Particulars ( cr) |
Mar 2022 | Mar 2021 | % Chg |
| Net Sales | 35.19 | 24.26 | 45.05 |
| Other Income | 0.53 | 0.55 | -3.64 |
| Total Income | 35.72 | 24.82 | 43.92 |
| Total Expenses | 25.39 | 19.07 | 33.14 |
| Operating Profit | 10.33 | 5.74 | 79.97 |
| Net Profit | -15.07 | 1.14 | -1421.93 |
| Equity Capital | 28.69 | 28.69 | - |
Lyka Labs Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Fredun Pharma | 847.80 | 1.69 | 377.27 |
| Ind-Swift Labs. | 58.55 | 0.09 | 345.97 |
| Kwality Pharma | 329.40 | -2.73 | 341.92 |
| Lyka Labs | 118.10 | 0.04 | 338.83 |
| Albert David | 535.65 | 6.76 | 305.86 |
| Zim Laboratories | 187.25 | -2.19 | 304.09 |
| Bafna Pharma. | 125.00 | 0.04 | 295.75 |
Lyka Labs Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherLyka Labs Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 0.98% | 1.54% | 2.66% | 2.65% |
| 1 Month | -6.82% | -6.59% | -2.45% | -2.64% |
| 3 Month | -15.79% | -15.30% | -8.45% | -8.85% |
| 6 Month | -53.16% | -53.36% | -7.70% | -7.67% |
| 1 Year | 96.51% | 98.08% | 0.05% | -0.58% |
| 3 Year | 444.24% | 433.56% | 34.78% | 34.19% |
Lyka Labs Ltd - STOCK STRENGTH
| Today's Low/High | 115.15 |
|
119.05 |
| Week Low/High | 102.50 |
|
123.00 |
| Month Low/High | 102.50 |
|
136.00 |
| YEAR Low/High | 55.75 |
|
267.00 |
| All TIME Low/High | 8.46 |
|
267.00 |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
